BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33226541)

  • 1. Prior testosterone replacement therapy may impact spermatogenic response to combined gonadotropin therapy in severe congenital hypogonadotropic hypogonadism.
    Shah R; Patil V; Sarathi V; Lila AR; Zacharin M; Krishnappa B; Sehemby M; Jaiswal SK; Jadhav PL; Ramteke-Jadhav S; Shah N; Bandgar T
    Pituitary; 2021 Jun; 24(3):326-333. PubMed ID: 33226541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropins for testicular descent in cryptorchid congenital hypogonadotropic hypogonadism males beyond infancy.
    Sharma S; Shah R; Patil V; Lila AR; Sarathi V; Shah N; Bandgar T
    J Pediatr Endocrinol Metab; 2021 Jul; 34(7):917-924. PubMed ID: 33894111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
    Antonio L; Caerels S; Jardi F; Delaunay E; Vanderschueren D
    Andrology; 2019 May; 7(3):302-306. PubMed ID: 30851011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulsatile gonadotropin releasing hormone therapy for spermatogenesis in congenital hypogonadotropic hypogonadism patients who had poor response to combined gonadotropin therapy.
    Huang Z; Wang X; Yu B; Ma W; Zhang P; Wu X; Nie M; Mao J
    Arch Endocrinol Metab; 2024 May; 68():e230101. PubMed ID: 38739523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulsatile gonadotropin-releasing hormone therapy is associated with earlier spermatogenesis compared to combined gonadotropin therapy in patients with congenital hypogonadotropic hypogonadism.
    Mao JF; Liu ZX; Nie M; Wang X; Xu HL; Huang BK; Zheng JJ; Min L; Kaiser UB; Wu XY
    Asian J Androl; 2017; 19(6):680-685. PubMed ID: 28051040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes and biochemical alterations during hormonal therapy in men with hypogonadotropic hypogonadism who have finished infertility treatment.
    Shiraishi K; Ohmi C; Matsuyama H
    Endocr J; 2021 Feb; 68(2):221-229. PubMed ID: 33012744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pulsatile Gonadorelin Pump Induces Earlier Spermatogenesis Than Cyclical Gonadotropin Therapy in Congenital Hypogonadotropic Hypogonadism Men.
    Zhang L; Cai K; Wang Y; Ji W; Cheng Z; Chen G; Liao Z
    Am J Mens Health; 2019; 13(1):1557988318818280. PubMed ID: 30569789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gonadotropin treatment for male partial congenital hypogonadotropic hypogonadism in Chinese patients.
    Hao M; Nie M; Yu BQ; Gao YJ; Wang X; Ma WL; Huang QB; Zhang R; Mao JF; Wu XY
    Asian J Androl; 2020; 22(4):390-395. PubMed ID: 31464203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Testicular growth and spermatogenesis: new goals for pubertal hormone replacement in boys with hypogonadotropic hypogonadism? -a multicentre prospective study of hCG/rFSH treatment outcomes during adolescence.
    Rohayem J; Hauffa BP; Zacharin M; Kliesch S; Zitzmann M;
    Clin Endocrinol (Oxf); 2017 Jan; 86(1):75-87. PubMed ID: 27467188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Pulsatile Gonadotropin-Releasing Hormone Therapy in Male Patients: Comparison between Pituitary Stalk Interruption Syndrome and Congenital Hypogonadotropic Hypogonadism.
    Huang Q; Mao J; Wang X; Yu B; Ma W; Ji W; Zhu Y; Zhang R; Sun B; Zhang J; Nie M; Wu X
    Endocr Pract; 2022 May; 28(5):521-527. PubMed ID: 35218954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year comparison of testicular responses to pulsatile gonadotropin-releasing hormone and exogenous gonadotropins from the inception of therapy in men with isolated hypogonadotropic hypogonadism.
    Liu L; Banks SM; Barnes KM; Sherins RJ
    J Clin Endocrinol Metab; 1988 Dec; 67(6):1140-5. PubMed ID: 3142911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of human chorionic gonadotropin combined with human menopausal gonadotropin and a gonadotropin-releasing hormone pump for male adolescents with congenital hypogonadotropic hypogonadism.
    Liu Y; Ren XY; Peng YG; Chen SK; Cheng XR; Qin M; Wang XL; Song YN; Fan LJ; Gong CX
    Chin Med J (Engl); 2021 Mar; 134(10):1152-1159. PubMed ID: 33813517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment.
    Chen Y; Sun T; Niu Y; Wang D; Xiong Z; Li C; Liu K; Qiu Y; Sun Y; Gong J; Wang T; Wang S; Xu H; Liu J
    J Sex Med; 2020 Apr; 17(4):645-657. PubMed ID: 32171629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Spermatogenesis of pulsatile gonadotropin-releasing hormone infusion versus gonadotropin therapy in male idiopathic hypogonadotropic hypogonadism].
    Huang B; Mao J; Xu H; Wang X; Liu Z; Nie M; Wu X
    Zhonghua Yi Xue Za Zhi; 2015 May; 95(20):1568-71. PubMed ID: 26463603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Congenital combined pituitary hormone deficiency patients have better responses to gonadotrophin-induced spermatogenesis than idiopathic hypogonadotropic hypogonadism patients.
    Mao J; Xu H; Wang X; Huang B; Liu Z; Zhen J; Nie M; Min L; Wu X
    Hum Reprod; 2015 Sep; 30(9):2031-7. PubMed ID: 26141714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Outcome Predictors of Gonadotropin Treatment for Male Congenital Hypogonadotropic Hypogonadism: A Retrospective Study of 223 Patients.
    Liu Z; Mao J; Wu X; Xu H; Wang X; Huang B; Zheng J; Nie M; Zhang H
    Medicine (Baltimore); 2016 Mar; 95(9):e2867. PubMed ID: 26945370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gonadotropin Therapy Once a Week for Spermatogenesis in Hypogonadotropic Hypogonadism.
    Ma W; Mao J; Nie M; Wang X; Zheng J; Liu Z; Yu B; Xiong S; Hao M; Gao Y; Ji W; Huang Q; Zhang R; Li S; Zhao Y; Sun B; Wu X
    Endocr Pract; 2021 Nov; 27(11):1119-1127. PubMed ID: 33915281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism.
    Saal W; Happ J; Cordes U; Baum RP; Schmidt M
    Fertil Steril; 1991 Aug; 56(2):319-24. PubMed ID: 1906410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in levels of testosterone, insulin sensitivity and metabolic profiles during GnRH therapy: Reciprocity between insulin sensitivity and pituitary responsiveness to GnRH in teenage and young male patients with congenital hypogonadotropic hypogonadism.
    Fan HQ; Wang YC; He W; Zhou HW; Yang T
    Clin Endocrinol (Oxf); 2022 Dec; 97(6):783-791. PubMed ID: 36181235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of hormonal treatment in hypogonadotropic hypogonadism: more than ten years experience.
    Yang L; Zhang SX; Dong Q; Xiong ZB; Li X
    Int Urol Nephrol; 2012 Apr; 44(2):393-9. PubMed ID: 21989858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.